Skip to main content
Caplight Logo









Contrea株式会社

Contrea株式会社

Private
TokyoHealthcare & Life Scienceshttps://www.contrea.jp/

Last Round

Series A

Jan 23, 2026

Total Funding Raised

$7.33M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Contrea株式会社 is a healthtech company that develops and provides MediOS, a patient-facing digital transformation (DX) platform for medical institutions.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Vertical SaaS, EHR & EMR, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

hospital SaaSpatient communication platformhospital workflow automationpatient engagement platformelectronic informed consentdigital front doore-consentdigital questionnairespatient education videosvertical SaaSHealthTechinpatient supportpaperless hospitalLINE integration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Contrea株式会社 Comparables

Compare Contrea株式会社 with similar companies based on industry and business-model similarity.

Contrea株式会社 comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
株式会社OPERe
88%
株式会社レイヤード
81%
Medley, Inc.
68%

Contrea株式会社 Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 23, 2026
Pre SeedNov 16, 2021
SeedJul 28, 2020

Key People

Founding team and executive leadership

Kawabata Kazuhiro

Chief Executive Officer

Executive Team

Contrea株式会社 Investors

Notable investors and investment history

Contrea株式会社 investors
InvestorRounds
ITOCHU Technology VenturesSeries A
Mizuho CapitalSeries A
Mizuho BankSeries A
East VenturesPre Seed, Series A, Seed
Coral CapitalSeries A, Pre Seed
Mitsui Sumitomo Insurance Capital Co., Ltd.Series A
Chiba Dojo FundPre Seed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 23, 2026

    $6.1M round led by ITOCHU Technology Ventures

  • Jan 21, 2026

    Monthly visitors increased 30% MoM, reaching 5.5K.

Contrea株式会社 Filings

Explore SEC and related filing metadata, where available.

Contrea株式会社 filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Contrea株式会社's valuation, stock price, and market status.

Is Contrea株式会社 a public or private company?

Contrea株式会社 is a private company.

What is the current stock price of Contrea株式会社?

Contrea株式会社 is a private company with no public stock price. No recent secondary market data is available.

How much is Contrea株式会社 worth (valuation)?

Valuation information for Contrea株式会社 is not publicly available.

Can I buy Contrea株式会社 stock?

Contrea株式会社 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Contrea株式会社's last funding round?

Contrea株式会社's most recent funding round was Series A on January 23, 2026.

Who are the main investors in Contrea株式会社?

Key investors in Contrea株式会社 include ITOCHU Technology Ventures, East Ventures, Coral Capital.

Will Contrea株式会社 IPO soon?

No public IPO plans have been announced for Contrea株式会社.

How can I track Contrea株式会社 secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Contrea株式会社's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Employee Range13
Year Founded2020
Last FundingJan 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?